Corvus Pharmaceuticals Ownership | Who Owns Corvus Pharmaceuticals?
Corvus Pharmaceuticals Ownership Summary
Corvus Pharmaceuticals is owned by 78.71% institutional investors, 3.51% insiders, and 17.78% retail investors. Orbimed advisors is the largest institutional shareholder, holding 7.96% of CRVS shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.43% of its assets in Corvus Pharmaceuticals shares.
CRVS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Corvus Pharmaceuticals | 78.71% | 3.51% | 17.78% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 7.17M | 7.96% | $107.05M |
| Blackrock funding, inc. /de | 7.14M | 7.93% | $106.65M |
| State street | 4.47M | 4.97% | $66.84M |
| Vanguard group | 3.87M | 4.68% | $29.83M |
| Price t rowe associates inc /md/ | 3.79M | 4.21% | $56.61M |
| Vanguard capital management | 3.29M | 3.66% | $49.19M |
| Adams street partners | 3.28M | 3.64% | $48.94M |
| Vivo capital | 2.81M | 3.12% | $41.92M |
| Wellington management group llp | 2.73M | 3.04% | $40.81M |
| Perceptive advisors | 2.67M | 2.96% | $39.85M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Adams street partners | 3.28M | 11.06% | $48.94M |
| Foresite capital management vi | 1.83M | 4.26% | $27.36M |
| Vivo capital | 2.81M | 3.83% | $41.92M |
| Catalio capital management, lp | 1.08M | 3.03% | $16.15M |
| Orbimed advisors | 7.17M | 1.99% | $107.05M |
| Dcf advisers | 637.50K | 1.68% | $9.52M |
| Blue owl capital lp | 608.60K | 1.37% | $9.09M |
| Boxer capital management | 1.10M | 1.24% | $16.43M |
| Braidwell lp | 2.13M | 1.18% | $31.77M |
| Towerview | 70.00K | 0.69% | $1.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 7.14M | 0.00% | 978.39K |
| State street | 4.47M | 0.00% | 908.10K |
| Price t rowe associates inc /md/ | 3.79M | 0.01% | 871.83K |
| Eversept partners, lp | 747.99K | 0.58% | 747.99K |
| Bank of america corp /de/ | 757.80K | 0.00% | 520.79K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Samlyn capital | - | - | -4.07M |
| Point72 asset management | - | - | -2.88M |
| Commodore capital lp | - | - | -2.26M |
| Bioimpact capital | - | - | -1.67M |
| Morgan stanley | 1.34M | 0.00% | -1.15M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Eversept partners, lp | 747.99K | 0.58% | 747.99K | $11.18M |
| Trexquant investment lp | 296.35K | 0.03% | 296.35K | $4.43M |
| Sixth street partners management company | 208.12K | 0.00% | 208.12K | $3.11M |
| Swiss national bank | 126.50K | 0.00% | 126.50K | $1.89M |
| Stempoint capital lp | 96.44K | 0.14% | 96.44K | $710.75K |
Sold Out
| Holder | Change |
|---|---|
| Advisory services network | -1.00 |
| Mai capital management | -7.00 |
| Twin peaks wealth advisors | -7.00 |
| Parallel advisors | -20.00 |
| Ifp advisors | -24.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 186 | 7.51% | 70,834,876 | 1.23% | 78 | 1.30% | 112 | -11.11% | 40 | 42.86% |
| Mar 31, 2026 | 64 | -51.88% | 8,345,679 | -82.12% | 10 | 0.33% | 43 | -39.44% | 14 | -53.33% |
| Dec 31, 2025 | 83 | -22.43% | 26,771,704 | -35.76% | 32 | 1.13% | 44 | -25.42% | 17 | - |
| Sep 30, 2025 | 106 | 6.00% | 41,641,007 | -0.34% | 53 | 1.86% | 59 | -7.81% | 17 | 21.43% |
| Jun 30, 2025 | 99 | -4.81% | 41,766,678 | 15.16% | 53 | 2.12% | 63 | 61.54% | 13 | -55.17% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 2.89M | 3.43% | 6.63K |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.41M | 2.86% | 32.97K |
| Vanguard Total Stock Mkt Idx Inv | 2.37M | 2.82% | 83.20K |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.37M | 2.82% | 83.20K |
| Vanguard US Total Market Shares ETF | 1.58M | 2.32% | - |
| iShares Russell 2000 ETF | 1.73M | 2.06% | -30.82K |
| T. Rowe Price New Horizons | 963.96K | 1.15% | 242.00K |
| US Small-Cap Growth II Equity Comp | 963.96K | 1.15% | 241.68K |
| Vanguard Institutional Extnd Mkt Idx Tr | 853.51K | 1.01% | 9.03K |
| Polar Capital Healthcare Opports Inc | 830.54K | 0.99% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Moore David Scott | - | Buy | $250.24K |
| May 18, 2026 | MILLER RICHARD A MD | President and CEO | Buy | $23.20K |
| May 18, 2026 | MILLER RICHARD A MD | President and CEO | Buy | $60.25K |
| Jun 27, 2025 | ORBIMED ADVISORS LLC | Sell | $4.89M | |
| Jun 27, 2025 | Thompson Peter A. | Sell | $4.89M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | 2 | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q2 | - | 2 |
| 2024 Q4 | - | - |
CRVS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools